Percutaneous Treatment of XXXX : Results of 12 Cases.

@entity1 @entity8434 @entity2601 @entity281
PURPOSE: @entity8434 ( @entity8434 ) in the spleen is a rare disease even in endemic regions. The aim of this study was to examine the efficacy of percutaneous treatment for splenic @entity8434 . MATERIALS AND METHODS: Twelve @entity1 (four @entity1 , eight @entity1 ) with splenic @entity8434 were included in this study. For percutaneous treatment, @entity2601 and CE3A splenic hydatid cysts were treated with either the PAIR (puncture, aspiration, injection, respiration) technique or the catheterization technique. RESULTS: Eight of the hydatid cysts were treated with the PAIR technique and four were treated with catheterization. The volume of all cysts decreased significantly during the follow-up period. No complication occurred in seven of 12 @entity1 . Abscess developed in four @entity1 . Two @entity1 underwent splenectomy due to @entity281 developed after percutaneous treatment, while the spleen was preserved in 10 of 12 @entity1 . Total hospital stay was between 1 and 18  days. Hospital stay was longer and the rate of @entity281 was higher in the catheterization group. Follow-up period was 5-117  months (mean, 44.8  months), with no recurrence observed. CONCLUSION: The advantages of the percutaneous treatment are its minimal invasive nature, short hospitalization duration, and its ability to preserve splenic tissue and function. As the catheterization technique is associated with higher abscess risk, we suggest that the PAIR procedure should be the first percutaneous treatment option for splenic @entity8434 .
